Published in Biochem J on April 15, 2000
Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med (2012) 1.99
An overview of small-molecule inhibitors of VEGFR signaling. Nat Rev Clin Oncol (2009) 1.80
The role of VEGF receptors in angiogenesis; complex partnerships. Cell Mol Life Sci (2006) 1.63
VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med (2012) 1.31
IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis. PLoS One (2008) 1.22
ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation. EMBO J (2001) 1.12
Vascular endothelial growth factor receptor 1 contributes to Escherichia coli K1 invasion of human brain microvascular endothelial cells through the phosphatidylinositol 3-kinase/Akt signaling pathway. Infect Immun (2010) 0.77
Loss of phospholipase D2 impairs VEGF-induced angiogenesis. BMB Rep (2016) 0.75
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem (1987) 59.79
High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr Genet (1989) 31.80
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (1996) 18.47
Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell (1993) 16.91
Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (1989) 16.71
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (1993) 15.70
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (1995) 15.15
The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics (1996) 11.71
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell (1998) 10.32
Vascular endothelial growth factor (VEGF) and its receptors. FASEB J (1999) 10.09
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (1995) 9.84
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell (1992) 6.86
Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem (1994) 6.18
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest (1989) 5.71
Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol Cell Biol (1995) 5.71
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood (1996) 5.31
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (1994) 5.19
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res (1999) 4.23
The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem (1996) 3.53
Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci U S A (1993) 3.01
An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science (1994) 2.80
Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest (1993) 2.71
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res (1996) 2.58
Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J (1989) 2.14
The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene (1997) 2.13
Human vascular permeability factor. Isolation from U937 cells. J Biol Chem (1989) 2.12
A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene (1995) 2.07
Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem (1997) 2.07
Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J Biol Chem (1995) 2.04
Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization. Oncogene (1999) 1.71
The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J Biol Chem (1999) 1.44
A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. Oncogene (1996) 1.26
Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues. J Biol Chem (1999) 1.21
Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor. Biochem Biophys Res Commun (1994) 1.21
Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene (1998) 1.19
A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain. Proc Natl Acad Sci U S A (1996) 1.11
Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites. Biochem Biophys Res Commun (1997) 1.11
N-Shc and Sck, two neuronally expressed Shc adapter homologs. Their differential regional expression in the brain and roles in neurotrophin and Src signaling. J Biol Chem (1998) 1.05
Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules. J Biol Chem (1998) 1.04
Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding. J Biol Chem (1995) 1.03
N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway. Oncogene (1996) 0.98
Sck interacts with KDR and Flt-1 via its SH2 domain. Biochem Biophys Res Commun (1998) 0.96
Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2. Biochem Biophys Res Commun (1998) 0.90
Binding of Shc to the NPXY motif is mediated by its N-terminal domain. J Biol Chem (1995) 0.79
Identification of clones that encode chicken tropomyosin by direct immunological screening of a cDNA expression library. Proc Natl Acad Sci U S A (1983) 6.00
Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science (1986) 4.99
Microinjection and localization of a 130K protein in living fibroblasts: a relationship to actin and fibronectin. Cell (1980) 4.87
Rapid purification of mammalian 70,000-dalton stress proteins: affinity of the proteins for nucleotides. Mol Cell Biol (1985) 4.75
The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature (1984) 4.61
A rapid purification of alpha-actinin, filamin, and a 130,000-dalton protein from smooth muscle. J Biol Chem (1980) 4.50
ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol Cell Biol (1994) 4.49
Co-existence of vinculin and a vinculin-like protein of higher molecular weight in smooth muscle. J Biol Chem (1982) 4.42
Nuclear and nucleolar localization of the 72,000-dalton heat shock protein in heat-shocked mammalian cells. J Biol Chem (1984) 4.20
Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell (1984) 3.81
Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell (1985) 3.73
10-nm filaments are induced to collapse in living cells microinjected with monoclonal and polyclonal antibodies against tubulin. J Cell Biol (1984) 3.51
p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol (2000) 2.96
Purification of the major mammalian heat shock proteins. J Biol Chem (1982) 2.79
Biochemical characterization of the mammalian stress proteins and identification of two stress proteins as glucose- and Ca2+-ionophore-regulated proteins. J Biol Chem (1983) 2.78
Regulation of actin microfilament integrity in living nonmuscle cells by the cAMP-dependent protein kinase and the myosin light chain kinase. J Cell Biol (1988) 2.72
Paradoxical relations of drug treatment with mortality in older persons. Epidemiology (2001) 2.52
The common 90-kd protein component of non-transformed '8S' steroid receptors is a heat-shock protein. EMBO J (1985) 2.50
Non-muscle alpha actinins are calcium-sensitive actin-binding proteins. Nature (1981) 2.35
Isolation of phosphorylated peptides and proteins on ion exchange papers. Anal Biochem (1978) 2.33
Direct visualization of fluorescein-labeled microtubules in vitro and in microinjected fibroblasts. J Cell Biol (1981) 2.33
Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev (2000) 2.21
Molecular and cellular effects of heat-shock and related treatments of mammalian tissue-culture cells. Cold Spring Harb Symp Quant Biol (1982) 2.18
Fluorescent localization of contractile proteins in tissue culture cells. Methods Enzymol (1982) 2.12
RB-dependent S-phase response to DNA damage. Mol Cell Biol (2000) 2.08
Expression of the ERBB3 gene product in breast cancer. Br J Cancer (1992) 2.01
Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells. Mol Cell Biol (1988) 2.00
Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev (1998) 1.99
Disruption of the in vivo distribution of the intermediate filaments in fibroblasts through the microinjection of a specific monoclonal antibody. Cell (1981) 1.98
Microinjection of fluorescently labeled alpha-actinin into living fibroblasts. Proc Natl Acad Sci U S A (1979) 1.95
HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem (1993) 1.91
A Rab1 mutant affecting guanine nucleotide exchange promotes disassembly of the Golgi apparatus. J Cell Biol (1994) 1.91
Optimal spatial requirements for the location of basic residues in peptide substrates for the cyclic AMP-dependent protein kinase. J Biol Chem (1980) 1.88
Elevation of tubulin levels by microinjection suppresses new tubulin synthesis. Nature (1983) 1.68
The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements. Nature (1988) 1.66
Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins. Nature (1984) 1.62
Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein. Nature (1985) 1.61
Studies on the kinetic mechanism of the catalytic subunit of the cAMP-dependent protein kinase. J Biol Chem (1983) 1.61
Characterization of antibodies to smooth muscle myosin kinase and their use in localizing myosin kinase in nonmuscle cells. Proc Natl Acad Sci U S A (1981) 1.55
A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc Natl Acad Sci U S A (1994) 1.53
Gq- and ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha 1-adrenergic stimulation. J Biol Chem (1994) 1.41
Transport of microinjected proteins into peroxisomes of mammalian cells: inability of Zellweger cell lines to import proteins with the SKL tripeptide peroxisomal targeting signal. Mol Cell Biol (1992) 1.39
Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. Proc Natl Acad Sci U S A (1993) 1.38
Alpha-actinin and vinculin from nonmuscle cells: calcium-sensitive interactions with actin. Cold Spring Harb Symp Quant Biol (1982) 1.32
NDF/heregulin stimulates the phosphorylation of Her3/erbB3. FEBS Lett (1994) 1.29
Modulation of vimentin containing intermediate filament distribution and phosphorylation in living fibroblasts by the cAMP-dependent protein kinase. J Cell Biol (1989) 1.28
Simian virus 40 small t antigen cooperates with mitogen-activated kinases to stimulate AP-1 activity. Mol Cell Biol (1994) 1.27
Signal transduction through the cAMP-dependent protein kinase. Mol Cell Biochem (1993) 1.27
Dynamics of the distribution of cyclic AMP-dependent protein kinase in living cells. Proc Natl Acad Sci U S A (1990) 1.26
Distribution of fluorescently labeled alpha-actinin in living and fixed fibroblasts. J Cell Biol (1980) 1.26
Thermostable inhibitor of cAMP-dependent protein kinase enhances the rate of export of the kinase catalytic subunit from the nucleus. J Biol Chem (1994) 1.22
Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway. J Biol Chem (1996) 1.20
G12 requirement for thrombin-stimulated gene expression and DNA synthesis in 1321N1 astrocytoma cells. J Biol Chem (1995) 1.18
Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts. Mol Cell Biol (1994) 1.17
Effects of age and gender on autonomic control of blood pressure dynamics. Hypertension (1999) 1.14
Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med (2000) 1.13
Expression of c-fos and AP-1 activity in senescent human fibroblasts is not sufficient for DNA synthesis. J Cell Biol (1992) 1.12
Talin contains three similar vinculin-binding sites predicted to form an amphipathic helix. Biochem J (1999) 1.10
Inhibition of cyclic AMP-dependent protein kinase by analogues of a synthetic peptide substrate. J Biol Chem (1978) 1.10
Protein phosphatase 2A potentiates activity of promoters containing AP-1-binding elements. Mol Cell Biol (1993) 1.09
Transport of microinjected alcohol oxidase from Pichia pastoris into vesicles in mammalian cells: involvement of the peroxisomal targeting signal. J Cell Biol (1992) 1.08
12/15-lipoxygenase translocation enhances site-specific actin polymerization in macrophages phagocytosing apoptotic cells. J Biol Chem (2001) 1.08
Construction of mammalian cell lines with indicator genes driven by regulated promoters. Ciba Found Symp (1990) 1.08
The erbB-3 gene in human pancreatic cancer. J Pathol (1992) 1.07
Isolation and sequence of a cDNA clone that contains the entire coding region for chicken smooth-muscle alpha-tropomyosin. J Biol Chem (1984) 1.07
Interference with endogenous ras function inhibits cellular responses to wounding. J Cell Biol (1993) 1.07
The mammalian stress response and the cytoskeleton: alterations in intermediate filaments. Ann N Y Acad Sci (1985) 1.06
Disruption of the three cytoskeletal networks in mammalian cells does not affect transcription, translation, or protein translocation changes induced by heat shock. Mol Cell Biol (1985) 1.06
Renal cell carcinoma in pregnancy. Cancer (1986) 1.05
Mediation of growth factor induced DNA synthesis and calcium mobilization by Gq and Gi2. J Cell Biol (1993) 1.04
A requirement for Ras protein function in thrombin-stimulated mitogenesis in astrocytoma cells. J Biol Chem (1993) 1.04
RalGDS functions in Ras- and cAMP-mediated growth stimulation. J Biol Chem (1997) 1.03
The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death. Oncogene (1999) 1.02
Intracellular mediators of c-fos induction. Cold Spring Harb Symp Quant Biol (1988) 1.01
Recombinant cyclic AMP response element binding protein (CREB) phosphorylated on Ser-133 is transcriptionally active upon its introduction into fibroblast nuclei. J Biol Chem (1994) 1.00
Cloning of the chick hsp 90 cDNA in expression vector. Nucleic Acids Res (1985) 1.00
Transcriptional and post-transcriptional regulation of c-fos expression by the tumor promoter okadaic acid. Oncogene (1991) 0.99
c-Myc cooperates with activated Ras to induce the cdc2 promoter. Mol Cell Biol (1994) 0.99
Induction of a cyclic AMP-responsive gene in living cells requires the nuclear factor CREB. Mol Cell Biol (1991) 0.99
Inhibition of DNA synthesis in living cells by microinjection of Gi2 antibodies. J Biol Chem (1992) 0.99
Inhibition of Raf-1 signaling by a monoclonal antibody, which interferes with Raf-1 activation and with Mek substrate binding. Oncogene (1996) 0.99
Regulation of c-fos and c-jun protooncogene expression by the Ca(2+)-ATPase inhibitor thapsigargin. Proc Natl Acad Sci U S A (1991) 0.98
Consumer-run service participation, recovery of social functioning, and the mediating role of psychological factors. Psychiatr Serv (2001) 0.94
MyoD induced cell cycle arrest is associated with increased nuclear affinity of the Rb protein. Mol Biol Cell (1993) 0.92
Localization of phospholipase A2 in normal and ras-transformed cells. J Cell Biol (1988) 0.91
Effect of the thermostable protein kinase inhibitor on intracellular localization of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem (1992) 0.91
Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD. Cancer Res (1998) 0.90
Retinoic acid-mediated growth inhibition of small cell lung cancer cells is associated with reduced myc and increased p27Kip1 expression. Int J Cancer (1999) 0.89
Thyrotropin-induced mitogenesis is Ras dependent but appears to bypass the Raf-dependent cytoplasmic kinase cascade. Mol Cell Biol (1995) 0.89
Differential regulation of jun family gene expression by the tumor promoter okadaic acid. New Biol (1991) 0.87
Inhibition of cell surface ruffling and fluid-phase pinocytosis by microinjection of anti-ras antibodies into living cells. J Cell Physiol Suppl (1987) 0.87
Autoantibodies to alpha(IIb)beta(3) in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on alpha(IIb). Blood (2001) 0.87
Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells. Oncogene (2000) 0.86
Microinjection of the catalytic subunit of cAMP-dependent protein kinase induces expression of the c-fos gene. Cold Spring Harb Symp Quant Biol (1988) 0.86
Inhibition of histone H1 kinase expression, retinoblastoma protein phosphorylation, and cell proliferation by the phosphatase inhibitor okadaic acid. Oncogene (1993) 0.85
Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product. New Biol (1990) 0.83
Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol Lett (2000) 0.83
Differential regulation of cellular activities by GTPase-activating protein and NF1. Mol Cell Biol (1993) 0.83
Identification of ErbB3-stimulated genes using modified representational difference analysis. Biochem J (1997) 0.83